Stock-Based Compensation | NOTE 11 – Stock-Based Compensation Under the terms of the 20 14 Plan, employees, certain consultants and advisors and non-employee members of the Company’s Board of Directors ha ve the opportunity to receive incentive and nonqualified grants of stock options, stock appreciation rights, restricted stock and other equity-based awards as approved by the Company’s Board of Directors . These award programs are used to attract, retain and motivate employees and to encourage individuals in key management roles to retain stock. The Company has a policy of issuing new shares to satisfy awards under the 2014 P lan. T he aggregate number of shares under the 20 14 Plan that may be issued pursuant to stock options or restricted stock grants i s 1,200,000 with n ot more than 1,000,000 of such shares available for issuance as restricted stock grants. There were 949,559 shares available for future grants under the 2014 Plan as of June 30, 2015 , of which 749,559 shares were available to be issued as restricted stock grants. Total stock-based compensation expense was $ 0.3 million for each of the three-month period s ended June 30, 2015 and June 30, 2014 . Total stock-based compensation expense was $ 1.2 million for the six - month period ended June 30, 2015 and $ 1.3 million for the six - month period ended June 30, 2014 . Excess tax benefits from stock-based payment arrangements increased cash provided by financing activities and decreased cash provided by operating a ctivities by $0.3 million and $0.6 million for the six - mont h period s ended June 30, 2015 and June 30, 2014 , respectively. Stock Options Option awards are generally granted with an exercise price equal to the market price of the Company’s stock at the date of the grant and have 7- to 10-year contractual terms. All options issued contain service conditions based on the participant’s continued service with the Company and may provide for accelerated vesting if there is a change in control as defined in the Equity Compensation Plans. Employee stock options generally vest over four years. The Company also issues stock options to non-employee independent directors. These options generally vest in one year. There were no stock options granted during the three-month and six -month periods ended June 30, 2015 and June 30, 2014 , respectively. A summary of option activity for the six - month period ended June 30, 2015 follows: Weighted Average Number of Exercise Price Options Shares Per Share Outstanding, December 31, 2014 193,351 $ 10.23 Granted — — Exercised (57,855) 9.62 Forfeited (80,728) 9.64 Expired — — Outstanding, June 30, 2015 54,768 11.74 During the three-month period ended June 30, 2015 the Company did not recognize compensation expense related to options. There was less than $ 0.1 million of compensation expense recognized related to options for the three-month period ended June 30, 2014 . During the six - month period ended June 30, 2015 the Company did not recognize compensation expense related to options. During the six - month period ended June 30, 2014 the Company recognized total compensation expense related to options of less than $ 0.1 million. There were 23,691 and 2,488 stock options exercised during the t hree-month periods ended June 30, 2015 and June 30, 2014 , respectively. The total pretax intrinsic value s of stock options exercised were $ 0.2 million and less than $ 0.1 million for the three-month periods ended June 30, 2015 and June 30, 2014 , respectively. The total pretax intrinsic value s of stock options exercised were $ 0.6 million and less than $ 0.1 million for the six - month period s ended June 30, 2015 and June 30, 2014 , respectively. The following table summarizes information about the stock options outstanding and exercisable as of June 30, 2015 : Options Outstanding Options Exercisable Weighted Weighted Aggregate Weighted Weighted Aggregate Average Average Intrinsic Average Average Intrinsic Range of Number Remaining Exercise Value Number Remaining Exercise Value Exercise Prices Outstanding Life (Years ) Price (In thousands) Exercisable Life (Years ) Price (In thousands) $ 7.17 - 7.79 6,960 1.3 $ 7.24 $ 67 6,960 1.3 $ 7.24 $ 67 $ 12.08 - 12.41 47,808 1.9 12.38 215 35,306 1.9 12.36 160 54,768 1.8 11.73 $ 282 42,266 1.8 11.52 $ 227 The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on the Company’s closing stock price of $16.88 as of June 30, 2015 , which would have been received by the option holders had all option holders exercised their options as of that date. As of June 30, 2015 , there was no future compensation cost related to non-vested stock options not yet recognized in the Consolidated Statements of Operations based on the most probable performance assumpti ons. As of June 30, 2015 , $ 0.2 million of additional potential compensation cost related to non-vested stock options has not been recognized due to performance targets not being achieved. However, in certain circumstances, these options may be s ubject to vesting prior to their expiration dates. The weighted average remaining term of these options is approximately 1.9 years. Restricted Stock Awards Restricted stock awards provide that, during the applicable vesting periods, the shares awarded may not be sold or transferred by the participant. The vesting period for restricted stock awards generally ranges from three to 10 years. All awards issued contain service conditions based on the participant’s continued service with the Company and may provide for accelerated vesting if there is a change in control as defined in the Equity Compensation Plan s . T he vesting of certain restricted shares may be accelerated to a minimum of three years based on achievement of various in dividual performance measures. Acceleration of expense for awards based on individual performance factors occurs when the achievement o f the performance criteria is determined. In addition, the Company has issued certain shares under a Management Stock Ownership Program. Under this program, restrictions on the shares lapse at the end of 10 years but may lapse (vest) in a minimum of thre e years if the employee continues in service at the Company and owns a matching number of other common shares in addition to the restricted shares. Of the total restricted stock awards granted during the six - month period ended June 30, 2015 , 71,480 shares may be subject to accelerated vesting based on individual performance factors ; no shares have vesting contingent upon performance factors. Vesting was accelerated in 2014 and 201 5 on certain awards based on the ach ievement of certain performance criteria determined annually, as described below. The Company also issues restricted stock to non-employee independent directors. These shares generally vest in seven years from the grant date or six months following the director’s termination from Board of Directors service. The following table summarizes the activity of the non-vested restricted stock during the six months ended June 30, 2015 : Weighted Average Grant-Date Non-vested restricted stock Shares Fair Value Outstanding at December 31, 2014 346,036 $ 15.99 Granted 145,793 17.34 Vested (120,687) 14.69 Forfeited (16,363) 18.46 Outstanding at June 30, 2015 354,779 16.87 During the three-month periods ended June 30, 2015 and June 30, 2014 , the Company granted restricted stock awards with grant date fair values totaling $ 0.5 million and $ 2.0 million, respectively. During the six - month periods ended June 30, 2015 and June 30, 2014 , the Company granted restricted stock awards with grant date fair values totaling $ 2.5 million and $ 2.0 million, respectively. As vesting occurs, or is deemed likely to occur, compensation expe nse is recognized over the requisite service period and additional paid-in capital is increased. The Company recognized $ 0.3 million of compensation expense related to restricted stock for each of the three-month periods ended June 30, 2015 and June 30, 2014 . The Company recognized $ 1.2 million and $ 1.3 million of compensation expense related to restricted stock for the six - month periods ended June 30, 2015 and June 30, 2014 , respectively. Of the $ 1.2 million total compensation expense related to restricted stock for the six -month period ended June 30, 2015 , approximately $ 0.5 million related to accelerated vesting during the first quarter of 2015 , based on achievement of certain performance criteria determined annually. Of the $ 1.3 million total compensation expense related to restricted stock for the six -month period ended June 30, 2014 , approximately $ 0.6 million related to accelerated vesting during the first quarter of 2014 , which was also based on the achievement of certain performance criteria determined annually. As of June 30, 2015 , there was $ 4.6 million of unrecognized compensation cost related to non-vested restricted stock compensation scheduled to be recognized over a weighted average period of 4.3 years. In the event individual performance targets are achieved, $ 1.8 million o f the unrecognized compensation cost would accelerate to be recognized over a weighted average period of 1.4 years. In addition, certain of the awards granted may result in the issuance of 57,650 additional shares of stock if ach ievement of certain targets is greater than 100 %. The expense related to the additional shares awarded will be dependent on the Company’s stock price when the achievement level is determined. The fair value of shares that vested during each of the three-m onth periods ended June 30, 2015 and June 30, 2014 was $ 0.5 million. The fair value of shares that vested during the six - month periods ended June 30, 2015 and June 30, 2014 was $ 2.2 million and $ 4.7 million, respectively. |